Cargando…
A novel cell culture system modeling the SARS-CoV-2 life cycle
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the global pandemic of COVID-19. SARS-CoV-2 is classified as a biosafety level-3 (BSL-3) agent, impeding the basic research into its biology and the development of effective antivirals. Here, we developed a biosafety level-2 (BSL-2)...
Autores principales: | Ju, Xiaohui, Zhu, Yunkai, Wang, Yuyan, Li, Jingrui, Zhang, Jiaxing, Gong, Mingli, Ren, Wenlin, Li, Sai, Zhong, Jin, Zhang, Linqi, Zhang, Qiangfeng Cliff, Zhang, Rong, Ding, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990224/ https://www.ncbi.nlm.nih.gov/pubmed/33711082 http://dx.doi.org/10.1371/journal.ppat.1009439 |
Ejemplares similares
-
Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2
por: Zhang, Shaojun, et al.
Publicado: (2021) -
Identification of functional cis-acting RNA elements in the hepatitis E virus genome required for viral replication
por: Ju, Xiaohui, et al.
Publicado: (2020) -
In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs
por: Sun, Lei, et al.
Publicado: (2021) -
Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption
por: Ren, Wenlin, et al.
Publicado: (2021) -
Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2
por: Liu, Yinghui, et al.
Publicado: (2021)